Mid-Afternoon Market Update: Crude Oil Drops Over 2%; Bottomline Technologies Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 0.87% to 35,585.26 while the NASDAQ rose 0.43% to 15,245.07. The S&P also fell, dropping 0.32% to 4,653.92.
Mid-Day Market Update: Dow Tumbles 500 Points; Abeona Therapeutics Shares Plummet
Midway through trading Friday, the Dow traded down 1.39% to 35,398 while the NASDAQ fell 0.30% to 15,134.89. The S&P also fell, dropping 0.92% to 4,625.58.
28 Stocks Moving In Friday’s Mid-Day Session
Gainers
Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.
Bellerophon Stock Surges After Positive Data From Sarcoidosis-Associated Pulmonary Hypertension Trial
Bellerophon Therapeutics Inc (NASDAQ: BLPH) shares are trading higher after
Bellerophon Reports Positive Top-Line Data From Phase 2 Acute Dose Escalation Study Of INOpulse For Treatment Of Pulmonary Hypertension Associated With Sarcoidosis
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced
The Daily Biotech Pulse: Cara’s Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 23)